Kezar Life Sciences, Inc. Disclosure

Kezar Life Sciences, Inc. (NASDAQ: KZR) is a client of PCG Advisory, Inc. KZR has an agreement in place to pay PCG a monthly cash fee of $7,500, for PCG investor awareness and investor relations advisory services.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. PCG investor awareness and advisory services include multimedia marketing and other awareness services.